Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine

Detalhes bibliográficos
Autor(a) principal: Seolin, Bruna Gazzi de Lima
Data de Publicação: 2019
Outros Autores: Nemec-Bakk, Ashley, Forsyth, Heidi, Kirk, Stefanie, Araújo, Alex Sander da Rosa, Schenkel, Paulo Cavalheiro, Belló-Klein, Adriane, Khaper, Neelam
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/199535
Resumo: The increased circulation of norepinephrine, found in the diseased heart as a result of sympathetic nervous system overactivation, is responsible for its cardiotoxic effects including pathological hypertrophy, cell death, and oxidative stress. Bucindolol is a third generation adrenergic blocker, which acts on the β1 and β2 receptors, and has additional α1 antagonist activity. Thus, the aim of this study was to investigate the action of bucindolol on oxidative stress, hypertrophy, cell survival, and cell death signaling pathways in H9c2 cardiac cells exposed to norepinephrine. H9c2 cells were incubated with 10 μM norepinephrine for 24 h in the presence or absence of bucindolol (10 μM) treatment for 8 h. Western blot was used to determine the expression of proteins for hypertrophy/survival and death signaling pathways. Flow cytometry was used to assess cell death via caspase-3/7 activity and propidium iodide and reactive oxygen species via measuring the fluorescence of CM-H2DCFDA. Norepinephrine exposure resulted in an increase in oxidative stress as well as cell death. This was accompanied by an increased protein expression of LC3B-II/I. The protein kinase B/mammalian target of the rapamycin (Akt/mTOR) pathway which is involved in cardiac remodeling process was activated in response to norepinephrine and was mitigated by bucindolol. In conclusion, bucindolol was able to modulate cardiac remodeling which is mediated by oxidative stress.
id UFRGS-2_c79160adca6bee13219163a2d68b9708
oai_identifier_str oai:www.lume.ufrgs.br:10183/199535
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Seolin, Bruna Gazzi de LimaNemec-Bakk, AshleyForsyth, HeidiKirk, StefanieAraújo, Alex Sander da RosaSchenkel, Paulo CavalheiroBelló-Klein, AdrianeKhaper, Neelam2019-09-20T03:45:43Z20191942-0994http://hdl.handle.net/10183/199535001099729The increased circulation of norepinephrine, found in the diseased heart as a result of sympathetic nervous system overactivation, is responsible for its cardiotoxic effects including pathological hypertrophy, cell death, and oxidative stress. Bucindolol is a third generation adrenergic blocker, which acts on the β1 and β2 receptors, and has additional α1 antagonist activity. Thus, the aim of this study was to investigate the action of bucindolol on oxidative stress, hypertrophy, cell survival, and cell death signaling pathways in H9c2 cardiac cells exposed to norepinephrine. H9c2 cells were incubated with 10 μM norepinephrine for 24 h in the presence or absence of bucindolol (10 μM) treatment for 8 h. Western blot was used to determine the expression of proteins for hypertrophy/survival and death signaling pathways. Flow cytometry was used to assess cell death via caspase-3/7 activity and propidium iodide and reactive oxygen species via measuring the fluorescence of CM-H2DCFDA. Norepinephrine exposure resulted in an increase in oxidative stress as well as cell death. This was accompanied by an increased protein expression of LC3B-II/I. The protein kinase B/mammalian target of the rapamycin (Akt/mTOR) pathway which is involved in cardiac remodeling process was activated in response to norepinephrine and was mitigated by bucindolol. In conclusion, bucindolol was able to modulate cardiac remodeling which is mediated by oxidative stress.application/pdfengOxidative medicine and cellular longevity. New York. Vol. 2019 (2019), 6325424, 11 p.Antagonistas adrenérgicos betaInsuficiência cardíacaEstresse oxidativoNorepinefrinaBucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrineEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001099729.pdf.txt001099729.pdf.txtExtracted Texttext/plain40547http://www.lume.ufrgs.br/bitstream/10183/199535/2/001099729.pdf.txtee61c8e3d3df86249ec071ba96418a39MD52ORIGINAL001099729.pdfTexto completo (inglês)application/pdf2643519http://www.lume.ufrgs.br/bitstream/10183/199535/1/001099729.pdfc5f44beecd8edf92dabab6b70335a4d6MD5110183/1995352023-08-16 03:32:12.79898oai:www.lume.ufrgs.br:10183/199535Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-08-16T06:32:12Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
title Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
spellingShingle Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
Seolin, Bruna Gazzi de Lima
Antagonistas adrenérgicos beta
Insuficiência cardíaca
Estresse oxidativo
Norepinefrina
title_short Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
title_full Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
title_fullStr Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
title_full_unstemmed Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
title_sort Bucindolol modulates cardiac remodeling by attenuating oxidative stress in H9c2 cardiac cells exposed to norepinephrine
author Seolin, Bruna Gazzi de Lima
author_facet Seolin, Bruna Gazzi de Lima
Nemec-Bakk, Ashley
Forsyth, Heidi
Kirk, Stefanie
Araújo, Alex Sander da Rosa
Schenkel, Paulo Cavalheiro
Belló-Klein, Adriane
Khaper, Neelam
author_role author
author2 Nemec-Bakk, Ashley
Forsyth, Heidi
Kirk, Stefanie
Araújo, Alex Sander da Rosa
Schenkel, Paulo Cavalheiro
Belló-Klein, Adriane
Khaper, Neelam
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Seolin, Bruna Gazzi de Lima
Nemec-Bakk, Ashley
Forsyth, Heidi
Kirk, Stefanie
Araújo, Alex Sander da Rosa
Schenkel, Paulo Cavalheiro
Belló-Klein, Adriane
Khaper, Neelam
dc.subject.por.fl_str_mv Antagonistas adrenérgicos beta
Insuficiência cardíaca
Estresse oxidativo
Norepinefrina
topic Antagonistas adrenérgicos beta
Insuficiência cardíaca
Estresse oxidativo
Norepinefrina
description The increased circulation of norepinephrine, found in the diseased heart as a result of sympathetic nervous system overactivation, is responsible for its cardiotoxic effects including pathological hypertrophy, cell death, and oxidative stress. Bucindolol is a third generation adrenergic blocker, which acts on the β1 and β2 receptors, and has additional α1 antagonist activity. Thus, the aim of this study was to investigate the action of bucindolol on oxidative stress, hypertrophy, cell survival, and cell death signaling pathways in H9c2 cardiac cells exposed to norepinephrine. H9c2 cells were incubated with 10 μM norepinephrine for 24 h in the presence or absence of bucindolol (10 μM) treatment for 8 h. Western blot was used to determine the expression of proteins for hypertrophy/survival and death signaling pathways. Flow cytometry was used to assess cell death via caspase-3/7 activity and propidium iodide and reactive oxygen species via measuring the fluorescence of CM-H2DCFDA. Norepinephrine exposure resulted in an increase in oxidative stress as well as cell death. This was accompanied by an increased protein expression of LC3B-II/I. The protein kinase B/mammalian target of the rapamycin (Akt/mTOR) pathway which is involved in cardiac remodeling process was activated in response to norepinephrine and was mitigated by bucindolol. In conclusion, bucindolol was able to modulate cardiac remodeling which is mediated by oxidative stress.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-09-20T03:45:43Z
dc.date.issued.fl_str_mv 2019
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/199535
dc.identifier.issn.pt_BR.fl_str_mv 1942-0994
dc.identifier.nrb.pt_BR.fl_str_mv 001099729
identifier_str_mv 1942-0994
001099729
url http://hdl.handle.net/10183/199535
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Oxidative medicine and cellular longevity. New York. Vol. 2019 (2019), 6325424, 11 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/199535/2/001099729.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/199535/1/001099729.pdf
bitstream.checksum.fl_str_mv ee61c8e3d3df86249ec071ba96418a39
c5f44beecd8edf92dabab6b70335a4d6
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447695275327488